Putting Product Launch in the Spotlight

In this ISSUE

Setting Your Launch Path

Pre-launch Prep: The Modern Protocol

Pharm Exec's 18th Annual Industry Audit

Editorial Feature

Product Launch: Five Paths Forward

Pharm Exec's feature profiling a selection of notable biopharma brands is switching gears in 2019. Instead of recognizing the "Brands of the Year," the theme is new beginnings and new promise, spotlighting five products with compelling product launch stories. Whether commercial firsts or important franchise expansions, these treatments all share unique paths to market entry–and tie strongly to the industry's broader product launch landscape.
... /Read more/

Launching Medical Devices in the Japanese Market - How to navigate regulatory and reimbursement approval
Thursday, October 31, 2019 at 11am EDT

Opinion

Who Will Head FDA?

Time is running out on Ned Sharpless' term as FDA acting commissioner, generating much talk as the administration shows interest in naming a new head for the agency.
... /Read more/

Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 29, 2019 at 11am JST

Rare Diseases

Commercialization Imperatives for Success in Rare Diseases

To ensure patients have timely access to expensive new therapies, biopharma companies have to address commercialization challenges with innovative measures.
... /Read more/

Japan Oncology Market – Best in Class Practices for Advancing Patient Outcomes
Tuesday, October 15, 2019 at 5pm JST

Calendar

/ 13th Hub and SPP Model Optimization – 9/26-9/27 /

/ 16th Annual Patient Summit USA – 10/2-10/3 /

/ Life Sciences West Coast Compliance Congress – 10/8-10/9 /

/ 7th Annual Coupon and Copay – 10/16-10/17 /

/ Rare Diseases & Orphan Products Breakthrough Summit – 10/21-10/22 /

Regulatory Affairs

"Sunshine" on Marketing, Research Payments Expands at Home and Abroad

As part of the legislation expanding the federal Open Payments program, drug and medical device manufacturers will have to report payments and other "transfers of value" to a broader range of health professionals.
... /Read more/

The Pharm Exec Podcast: Episode 40

Sponsored by Fingerpaint

Global Pharma Outlook

Janssen's company group chairman of Europe, Middle East, and Africa operations, Kris Sterkens speaks with Pharm Exec editors. Kris talks about his finance background, global pricing issues, and challenges and opportunities for EMEA biopharma breaking into the US market.
... /Read more/

update my profile / advertise with us / print & digital subscribe / visit pharmexec.com